These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
480 related items for PubMed ID: 28381688
21. Epstein-Barr virus central nervous system involvement in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Yin Q, Wang J, Wang Z. Ann Hematol; 2022 Nov; 101(11):2471-2476. PubMed ID: 36071294 [Abstract] [Full Text] [Related]
22. Requirement for etoposide in the initial treatment of Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis. Song Y, Wang Y, Wang Z. Br J Haematol; 2019 Sep; 186(5):717-723. PubMed ID: 31115044 [Abstract] [Full Text] [Related]
23. Hemophagocytic lymphohistiocytosis secondary to Epstein Barr virus and Leishmania co-infection in a toddler. DomInguez-Pinilla N, Baro-Fernández M, González-Granado LI. J Postgrad Med; 2015 Sep; 61(1):44-5. PubMed ID: 25511219 [Abstract] [Full Text] [Related]
24. Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Shiraishi A, Ohga S, Doi T, Ishimura M, Takimoto T, Takada H, Miyamoto T, Abe Y, Hara T. Pediatr Blood Cancer; 2012 Aug; 59(2):265-70. PubMed ID: 22183955 [Abstract] [Full Text] [Related]
25. Profiling of EBV-Encoded microRNAs in EBV-Associated Hemophagocytic Lymphohistiocytosis. Zhou C, Xie Z, Gao L, Liu C, Ai J, Zhang L, Shen K. Tohoku J Exp Med; 2015 Oct; 237(2):117-26. PubMed ID: 26423217 [Abstract] [Full Text] [Related]
26. Hemophagocytic lymphohistiocytosis secondary to Candida albicans and reactivated EBV infections: A case report and review of the literature. Yang W, Liu K, Zou F, Wang X, Yin J, Wu Y, Chai X, Zheng L. Indian J Pathol Microbiol; 2021 Oct; 64(1):192-194. PubMed ID: 33433441 [Abstract] [Full Text] [Related]
27. [Clinical features and outcome analysis of 83 childhood Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-2004 protocol]. Xiao L, Xian Y, Dai BT, Su YC, Xiao JW, Zheng QC, Zhao XD, Yu J. Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):668-72. PubMed ID: 22339824 [Abstract] [Full Text] [Related]
28. Sintilimab treatment for chronic active Epstein-Barr virus infection and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children. Chen R, Lin Q, Zhu Y, Shen Y, Xu Q, Tang H, Cui N, Jiang L, Dai X, Chen W, Li X. Orphanet J Rare Dis; 2023 Sep 22; 18(1):297. PubMed ID: 37736751 [Abstract] [Full Text] [Related]
29. Resolution of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis associated with rapid immune reconstruction after a single course of CHOP therapy. Chikagawa Y, Hikishima K, Mizumaki H, Sugimori C, Nakagishi Y, Yachie A, Nakao S. Int J Hematol; 2020 Dec 22; 112(6):889-893. PubMed ID: 32725606 [Abstract] [Full Text] [Related]
30. Dual Threat of Epstein-Barr Virus: an Autopsy Case Report of HIV-Positive Plasmablastic Lymphoma Complicating EBV-Associated Hemophagocytic Lymphohistiocytosis. Koizumi Y, Imadome KI, Ota Y, Minamiguchi H, Kodama Y, Watanabe D, Mikamo H, Uehira T, Okada S, Shirasaka T. J Clin Immunol; 2018 May 22; 38(4):478-483. PubMed ID: 29687211 [Abstract] [Full Text] [Related]
31. Fulminant gastrointestinal bleeding caused by EBV-triggered hemophagocytic lymphohistiocytosis: report of a case. Klein S, Schmidt C, La Rosée P, Pletz M, Harz S, Dirsch O, Fritzenwanger M, Stallmach A. Z Gastroenterol; 2014 Apr 22; 52(4):354-9. PubMed ID: 24718941 [Abstract] [Full Text] [Related]
32. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens. Chellapandian D, Das R, Zelley K, Wiener SJ, Zhao H, Teachey DT, Nichols KE, EBV-HLH Rituximab Study Group. Br J Haematol; 2013 Aug 22; 162(3):376-82. PubMed ID: 23692048 [Abstract] [Full Text] [Related]
33. [Hemophagocytic lymphohistiocytosis and Epstein-Barr virus infection in children]. Darteyre S, Ludwig C, Jeziorski E, Schved JF, Rodière M. Med Mal Infect; 2010 Jan 22; 40(1):18-26. PubMed ID: 19836912 [Abstract] [Full Text] [Related]
34. Secondary hemophagocytic lymphohistiocytosis in pediatric patients with visceral leishmaniasis and Epstein-Barr virus infection. Li Y, Li S, Lu N, Wang W, Wang D. Ann Hematol; 2024 May 22; 103(5):1541-1547. PubMed ID: 38467825 [Abstract] [Full Text] [Related]
35. Chronic active EBV infection associated with NK cell lymphoma and hemophagocytic lymphohistiocytosis in a 27-year-old woman: A case report. Wang YD, Wu LL, Ma LY, Shang XB, Li ZY, Wang W, Shen C, Yang JJ, Sun LX, Zhao CY. Medicine (Baltimore); 2019 Jan 22; 98(2):e14032. PubMed ID: 30633196 [Abstract] [Full Text] [Related]
39. Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature. Hu S, Bansal P, Lynch D, Rojas Hernandez CM, Dayao Z. J Med Case Rep; 2016 Dec 20; 10(1):365. PubMed ID: 27998299 [Abstract] [Full Text] [Related]
40. Clinical warning of hemophagocytic syndrome caused by Epstein-Barr virus. Shi J, Chu C, Yu M, Zhang D, Li Y, Fan Y, Yu Y, Luo Y, Zhou W. Ital J Pediatr; 2021 Jan 07; 47(1):3. PubMed ID: 33413556 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]